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Syphilis 
Recommended Treatment Schedules-1976 
We have been asked by the Venereal Disease Control Division of the Center for Dis-
ease Control, Atlanta, Georgia, to publish the following material. 
Penicillin continues to be the drug of choice for 
all stages of syphilis. Every effort should be made 
to document penicillin allergy before choosing 
other antibiotics because these antibiotics have 
been studied less extensively than penicillin. Phys-
icians are cautioned to use no less than the recom-
mended dosages of antibiotics. 
EARLY SYPHILIS (primary, secondary, latent 
syphilis of less than 1 year's duration) 
(1) Benzathine penicillin G-2.4 million units 
total by intramuscular injection at a single 
session. Benzathine penicillin G is the drug 
of choice because it provides effective treat-
ment in a single visit. * OR 
(2) Aqueous procaine penicillin G-4.8 million 
units total: 600,000 units by intramuscular 
injection daily for 8 days. OR 
(3) Procaine penicillin G in oil with 2% alumi-
num monostearate (PAM)-4.8 million 
units total by intramuscular injection: 2.4 
million units at first visit, and 1.2 million 
units at each of 2 subsequent visits 3 days 
apart. Although PAM is used in other coun-
tries, it is no longer available in the United 
States 
Patients who are allergic to penicillin 
(1) Tetracycline hydrochloride-500 mg 4 times 
a day by mouth for 15 days 1 hour before or 
2 hours after meals. OR 
(2) Erythromycin (stearate, ethylsuccinate or 
base)-500 mg 4 times a day by mouth for 
15 days. 
These antibiotics appear to be effective but 
have been evaluated less extensively than penicil-
lin. 
SYPHILIS OF MORE THAN 1 YEAR'S DURA-
TION (latent syphilis of indeterminate or more 
than 1 year's duration, cardiovascular, late benign, 
neurosyphilis) 
(1) Benzathine penicillin G-7.2 million units 
total: 2.4 million units by intramuscular in-
jection weekly for 3 successive weeks. OR 
(2) Aqueous procaine penicillin G-9.0 million 
units total: 600,000 units by intramuscular 
injection daily for 15 days. 
* Italics indicate commentary. 
The optimal treatment schedules for syphilis of 
greater than 1 year's duration have been less well 
established than schedules for early syphilis. In 
general, syphilis of longer duration requires higher-
dose therapy. Although therapy is recommended 
for established cardiovascular syphilis, there is 
little evidence that antibiotics reverse the pathol-
ogy associated with this disease. 
Cerebrospinal fluid (CSF) examination is manda-
tory in patients with suspected, symptomatic 
neurosyphilis. This examination is also desirable in 
other patients with syphilis of greater than 1 year's 
duration to exclude asymptomatic neurosyphilis. 
Published studies show that a total dose of 6.0-
9.0 million units of penicillin G results in a satis-
factory clinical response in approximately 90% of 
patients with neurosyphilis. There is more pub-
lished clinical experience with short-acting peni-
cillin preparations than with benzathine penicillin 
G. Some clinicians prefer to hospitalize patients 
with neurosyphilis, particularly if the patient is 
symptomatic or has not responded to initial ther-
apy. In these instances they treat patients with 
12-24 million units of aqueous crystalline penicillin 
G given intravenously each day (2-4 million units 
every 4 hours) for 10 days. 
Patients who are allergic to penicillin: 
(1) Tetracycline hydrochloride-500 mg 4 times 
a day by mouth for 30 days. OR 
(2) Erythromycin (stearate, ethylsuccinate or 
base)-500 mg 4 times a day by mouth for 
30 days. 
There are NO published clinical data which 
adequately document the efficacy of drugs other 
than penicillin for syphilis of more than 1 year's 
duration. Cerebrospinal fluid examinations are 
highly recommended before therapy with these 
reglmens. 
SYPHILIS IN PREGNANCY 
Evaluation of Pregnant Women 
All pregnant women should have a nontrepone-
mal serologic test for syphilis, such as the VDRL 
or RPR test, at the time of the first prenatal visit. 
The treponemal-tests such as the FTA-ABS tes t 
should not be used for routine screening. In women 
suspected of being at high risk for syphilis, a 
second nontreponemal test should be performed 
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during the third trimester. Seroreactive patients 
should be expeditiously evaluated. This evaluation 
should include a history and physical examination, 
as well as a qUantitative nontreponemal test and a 
confirmatory treponemal test. 
If the FTA-ABS test is nonreactive and there is 
no clinical evidence of syphilis, treatment may be 
withheld. Both the quant{tative nontreponemal 
test and the confirmatory test should be repeated 
within 4 weeks. If there is clinical or serologic evi-
dence of syphilis or if the diagnosis of syphilis can-
not be excluded with reasonable certainty, the pa-
tient should be treated as outlined below. 
Patients for whom there is documentation of 
adequate treatment for syphilis in the past need 
not be retreated unless there is clinical or serologic 
evidence of reinfection such as darkfield-positive 
lesions or a 4-fold titer rise of a quantitative non-
treponemal test. 
A. For patients at all stages of pregnancy who are 
not allergic to penicillin': Penicillin in dosage 
schedules appropriate for the stage of syphilis 
as recommended for the treatment of non-
pregnant patients. 
B. For patients of all stages of pregnancy who are 
allergi,c to penicillin: Erythromycin (stearate, 
ethylsuccinate or base) in dosage schedules 
appropriate for the stage of syphilis, as recom-
mended for the treatment of non-pregnant pa-
patients. Although these erythromycin sched-
ules appear safe for mother and fetus, their 
efficacy is not well established. Therefore, the 
documentation of penicillin allergy is particu-
larly important before treating a pregnant 
woman with erythromycin. Erythromycin estol-
ate and tetracycline are not recommended for 
syphilitic infections in pregnant women be-
cause of potential adverse effects on mother 
and fetus. 
Follow-up 
Pregnant women who have been treated for 
syphilis should have monthly quantitative nontre-
ponemal serologic tests for the remainder of the 
current pregnancy. Women who show a 4-fold rise 
in titer should be retreated. After delivery, follow-
up is as outlined for nonpregnant patients. 
CONGENITAL SYPHILIS 
Congenital syphilis may occur if the mother has 
;:yphilis during pregnancy. If the mother has re-
ceived adequate penicillin treatment during preg-
nancy, the risk to the infant is minimal. However, 
all infants should be examined carefully at birth 
and at frequent intervals thereafter until nontrepo-
nemal serologic tests are negative. 
Infected infants are frequently asymptomatic at 
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birth and may be seronegative if the maternal in-
fection occurred late in gestation. Infants should 
be treated at birth if maternal treatment was in-
adequate, unknown, with drugs other than peni-
cillin, or if adequate follow-up of the infant cannot 
be ensured. 
Infants with congenital syphilis should have a 
CSF examination before treatment. 
Infants with abnormal CSF: 
(1) Aqueous crystalline penicillin G, 50,000 
units/kg intramuscularly or intravenously 
daily in 2 divided doses for a minimum of 10 
days. OR 
(2) Aqueous procaine penicillin G, 50,000 units/ 
kg intramuscularly daily for a minimum of 
10 days. 
Infants with normal CSF: 
Benzathine penicillin G, 50,000 units/kg intra-
muscularly in a single dose. Although benzathine 
penicillin has been previously recommended and 
widely used, published clinical data on its efficacy 
in congenital neurosyphilis are lacking. If neuro-
syphilis cannot be excluded, the procaine or aque-
ous penicillin regimens are recommended. Since 
cerebrospinal fluid concentrations of penicillin 
achieved after benzathine penicillin are minimal 
to nonexistent, these revised recommendations 
seem more conservative and appropriate until 
clinical data on the efficacy of benzathine penicil-
lin can be accumulated. Other antibiotics are not 
recommended for neonatal congenital syphilis. 
Penicillin therapy for congenital syphilis after 
the neonatal period should be with the same 
dosages used for neonatal congenital syphilis. For 
larger children the total dose of penicillin need not 
exceed the dosage used in adult syphilis of more 
than 1 year's duration. After the neonatal period, 
the dosage of erythromycin and tetracycline for 
congenital syphilitics who are allergic to penicillin 
should be individualized but need not exceed dos-
ages used in adult syphilis of more than 1 year's 
duration. Tetracycline should not be given to chil-
dren less than 8 years of age. 
FOLLOW-UP AND RETREATMENT 
All patients with early syphilis and congenital 
syphilis should be encouraged to return for repeat 
quantitative nontreponemal tests 3, 6, and 12 
months after treatment. Patients with syphilis of 
more than 1 year's duration should also have a re-
peat serologic test 24 months after treatment. 
Careful follow-up serologic testing is particularly 
important in patients treated with antibiotics 
other than penicillin. Examination of CSF should 
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be planned as part of the last follow-up visit treat-
ment with alternative antibiotics. 
All patients with neurosyphilis must be carefully 
followed with serologic testing for at least 3 years. 
In addition, follow-up of these patients should in-
clude clinical reevaluation at 6-month intervals and 
repeat CSF examinations, particularly in patients 
treated with alternative antibiotics. 
The possibility of reinfection should always be 
considered when retreating patients with early 
syphilis. A CSF examination should be performed 
before retreatment unless reinfection and a diag-
nosis of early syphilis can be established. 
Retreatment should be considered when: 
(1) Clinical signs or symptoms of syphilis persist 
or recur; 
(2) There is a sustained 4-fold increase in the 
titer of an nontreponemal test; 
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(3) An initially high-titer nontreponemal test 
fails to show a 4-fold decrease within a year. 
Patients should be retreated with the schedules 
recommended for syphilis of more than 1 year's 
duration. In general, only 1 retreatment course is 
indicated because patients may maintain stable, 
low titers of nontreponemal tests or have irreversi-
ble anatomical damage. 
EPIDEMIOLOGIC TREATMENT 
Patients who have been exposed to infectious 
syphilis within the preceding 3 months and other 
pati~nts who on epidemiologic grounds are at high 
risk for syphilis should be treated as for early 
syphilis. Every effort should be made to establish 
a diagnosis in these cases. 
